Analyzing Establishment Labs (NASDAQ:ESTA) and Tauriga Sciences (OTCMKTS:TAUG)

Tauriga Sciences (OTCMKTS:TAUG) and Establishment Labs (NASDAQ:ESTA) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, analyst recommendations, valuation, profitability, risk and institutional ownership.

Valuation & Earnings

This table compares Tauriga Sciences and Establishment Labs”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tauriga Sciences	N/A	N/A	N/A	N/A	N/A
Establishment Labs	$166.02 million	12.05	-$84.60 million	($2.84)	-24.24

Tauriga Sciences has higher earnings, but lower revenue than Establishment Labs.

Profitability

This table compares Tauriga Sciences and Establishment Labs’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tauriga Sciences	N/A	N/A	N/A
Establishment Labs	-43.45%	-235.45%	-22.83%

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Tauriga Sciences and Establishment Labs, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tauriga Sciences	0	0	0	0	0.00
Establishment Labs	1	1	6	0	2.63

Establishment Labs has a consensus target price of $78.86, suggesting a potential upside of 14.55%. Given Establishment Labs’ stronger consensus rating and higher probable upside, analysts plainly believe Establishment Labs is more favorable than Tauriga Sciences.

Insider and Institutional Ownership

72.9% of Establishment Labs shares are held by institutional investors. 3.5% of Tauriga Sciences shares are held by company insiders. Comparatively, 11.4% of Establishment Labs shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Establishment Labs beats Tauriga Sciences on 6 of the 9 factors compared between the two stocks.

About Tauriga Sciences

Tauriga Sciences, Inc. produces and sells cannabidiol infused chewing gum under the Tauri-Gum brand name. It also develops anti-nausea products; and skin care products include CBD facemasks; CBD daily moisturizer; CBD anti-wrinkle dream, hand, and foot cream with hemp seed oil; CBD massage and body oil; CBD body revive roll-on; CBD transdermal patch; and CBD body spray. In addition, the company offers rainbow deluxe sampler pack, CBD non-GMO dietary supplements, and CBD scented bath bombs. It sells its products through e-commerce, distributors, and wholesale channels. The company has a collaboration agreement with Aegea Biotechnologies, Inc. to develop a rapid, multiplexed COVID-19 (novel coronavirus) test. Tauriga Sciences, Inc. was founded in 2001 and is headquartered in Wappingers Falls, New York.

About Establishment Labs

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.